Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - ACCOUNTS PAYABLE
Accounts Payable PRPH - ProPhase Labs, Inc.
9.38 M
LAST VALUE
15.56%
2 YEAR CAGR
84.66%
5 YEAR CAGR
24.96%
10 YEAR CAGR